MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma

W A Yeudall1, R Y Crawford, J F Ensley

  • 1Laboratory of Cellular Development and Oncology, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.

Carcinogenesis
|December 1, 1994
PubMed

Insights

The MTS1/CDK4I gene, a tumor suppressor, is frequently altered in head and neck squamous cell carcinoma (HNSCC). Mutations in this gene, including deletions, were observed in HNSCC cell lines, suggesting inactivation is an in vivo event.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The MTS1/CDK4I gene, encoding a cyclin kinase inhibitor, is located on chromosome 9p21.
  • This locus is a suspected site for a major tumor suppressor gene, potentially inactivated in head and neck squamous cell carcinoma (HNSCC).

Purpose of the Study:

  • To investigate the status of the MTS1/CDK4I gene in primary and metastatic HNSCC.
  • To identify abnormalities in the MTS1/CDK4I gene locus and its transcript in HNSCC.

Main Methods:

  • Utilized polymerase chain reaction (PCR) to examine the MTS1/CDK4I gene locus and transcript for abnormalities.
  • Analyzed 14 HNSCC cell lines for deletions and alterations in p16 mRNA.

Main Results:

  • Abnormalities in the MTS1/CDK4I gene were detected in all 14 HNSCC cell lines studied.
  • These included loss of exons 1 and/or 2, and deletions (2-16 base pairs) in p16 mRNA transcripts, leading to frame shifts.
  • Identical mutations were found in primary tumors and their corresponding metastases, indicating in vivo inactivation.

Conclusions:

  • The MTS1/CDK4I gene is frequently altered in HNSCC.
  • Mutations and deletions in the MTS1/CDK4I gene, leading to inactivation of p16 function, occur in vivo during tumor progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...